Neuro-Behavioral Clinical Research Inc.
Ensuring the Success of Clinical Trials

Clinical trials are essential for advancing the science of medicine and determining the best treatment strategies for critical diseases. However, patients often remain unresponsive or feel uncomfortable participating in these trials owing to the fear of untested treatments and unknown results. Patients have distrust in big pharma and the growing complexities around clinical trial protocols makes patient recruitment difficult.:

This is where Neuro-Behavioral Clinical Research steps in. With a dedicated, successful recruitment team combined with years of research, clinical, and administrative experience, Neuro-Behavioral Clinical Research addresses the patient enrollment challenge by conducting clinical research trials in both the in-patient and out-patient facilities.

“Our team has been working with us for more than 14 years. With a comprehensive understanding of the patient demographic tracking yearly data and the target audience, they streamline the patient recruitment process,” says Dr. Shishuka Malhotra, MD, CEO, Neuro-Behavioral Clinical Research Inc.

Neuro-Behavioral Clinical Research believes that the central vendors can provide many leads but most of them are not useful for running a clinical trial effectively. To solve this, the company’s recruitment staff reaches out to patients in real-time at its site level. They meet the patients within a day to assess if they would be appropriate for the particular trial.

Neuro-Behavioral Clinical Research also plays an important in patient advocacy. The mental health issues related to lockdown and the pandemic has especially been hard for people with mental health problems and the company has been offering patients free mental health assessments as well as memory screenings.

“It is important to put your mental health first, and we are here to help,” says Dr. Malhotra. Neuro-Behavioral Clinical Research’s free mental health assessments are performed by its trained mental health professionals. Further, the company has been making efforts to educate the local groups and communities such that they can understand that participating in clinical trials can benefit their own health. As the participating patients are closely monitored by Neuro Behavioral Clinical Research’s experienced staff, they can be sure of safety.

Our site has been advocating diversity in Clinical Research for over 4 years and put a process in place to improve participation of minority population. Another point of differentiation for Neuro-Behavioral Clinical Research is the company’s focus on conducting routine inter-rater reliability among iterates. The data that emerges out of this practice is used in training the team and making them better. In fact, the company has been collecting post-trial placebo separation and patient compliance data for 14 years which has been applauded by many sponsors nationally. This improves patients trust scientific processes and in turn improves participation. For example, three sponsors praised Neuro-Behavioral Clinical Research last year on the quality of data that the company had in place. More importantly, the company has been instrumental in pushing the envelope of new apps such as AiCure, which brings AI to the life sciences industry to guide data-driven decision-making for more meaningful clinical trials. It conducts all the studies with strict adherence to FDA and GCP guidelines and provides accurate data to sponsors, ensuring the ethical treatment of patients.

Neuro-Behavioral Clinical Research has been able to help more than 5000 patients on a year-by-year basis. Currently, the company’s primary objective is to improve diversity of the minority population in Alzheimers clinical trials. To this end, the company has collaborated with the Global Alzheimer’s Platform (GAP-Net).

With the experience that Dr. Malhotra and her team exhibits, Neuro-Behavioral Clinical Research looks all set to increase diversity in the clinical trial and expand its geographic space to include more patients at once. “We are a patient-first organization that ultimately benefits the CROs and sponsors,” concludes Dr. Malhotra.